文献速递其他结缔组织病自身炎症与 IgG4 相关病

儿童和青少年风湿性与肌肉骨骼疾病患者感染SARS-CoV-2的结局

Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
PubMed 文献 · Ann Rheum Dis · 2022-03-25

该研究基于欧洲风湿病协会联盟COVID-19登记处、CARRA登记处及CARRA赞助的COVID-19全球儿科风湿病数据库,纳入25个国家607例<19岁、患有风湿性与肌肉骨骼疾病(RMD)且报告SARS-CoV-2感染的儿童和青少年。43例(7%)住院,其中3例死亡;与幼年特发性关节炎相比,系统性红斑狼疮、混合性结缔组织病、血管炎或其他RMD(OR 4.3;95%CI 1.7至11)及自身炎症综合征(OR 3.0;95%CI 1.1至8.6)与住院相关,肥胖亦与住院相关(OR 4.0;95%CI 1.3至12)。

要点

  • 607例<19岁RMD合并SARS-CoV-2感染患儿中,43例(7%)住院,3例死亡。
  • 与JIA相比,SLE、混合性结缔组织病、血管炎或其他RMD住院OR 4.3(95%CI 1.7至11)。
  • 自身炎症综合征住院OR 3.0(95%CI 1.1至8.6),肥胖住院OR 4.0(95%CI 1.3至12)。

核心结论

  • 多数患有RMD的儿童和青少年感染SARS-CoV-2后未住院,但患有严重系统性RMD和肥胖者更可能住院。

研究设计与样本

  • 利用欧洲风湿病协会联盟COVID-19登记处、儿童关节炎和风湿病研究联盟(CARRA)登记处及CARRA赞助的COVID-19全球儿科风湿病数据库,获取报告SARS-CoV-2感染(推测或确诊)的RMD儿童和青少年数据,描述患者特征和疾病严重程度,并分析COVID-19住院相关因素。
  • 纳入607例<19岁、来自25个不同国家的RMD合并SARS-CoV-2感染儿童和青少年,其中大多数为幼年特发性关节炎(JIA;n=378;62%)。

主要发现

  • 43例(7%)患者住院,其中3例死亡。
  • 与JIA相比,系统性红斑狼疮、混合性结缔组织病、血管炎或其他RMD诊断与住院相关(OR 4.3;95%CI 1.7至11)。
  • 与JIA相比,自身炎症综合征诊断与住院相关(OR 3.0;95%CI 1.1至8.6)。
  • 肥胖与住院相关(OR 4.0;95%CI 1.3至12)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Some adults with rheumatic and musculoskeletal diseases (RMDs) are at increased risk of COVID-19-related death. Excluding post-COVID-19 multisystem inflammatory syndrome of children, children and young people (CYP) are overall less prone to severe COVID-19 and most experience a mild or asymptomatic course. However, it is unknown if CYP with RMDs are more likely to have more severe COVID-19. This analysis aims to describe outcomes among CYP with underlying RMDs with COVID-19. METHODS: Using the European Alliance of Associations for Rheumatology COVID-19 Registry, the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, and the CARRA-sponsored COVID-19 Global Paediatric Rheumatology Database, we obtained data on CYP with RMDs who reported SARS-CoV-2 infection (presumptive or confirmed). Patient characteristics and illness severity were described, and factors associated with COVID-19 hospitalisation were investigated. RESULTS: 607 CYP with RMDs <19 years old from 25 different countries with SARS-CoV-2 infection were included, the majority with juvenile idiopathic arthritis (JIA; n=378; 62%). Forty-three (7%) patients were hospitalised; three of these patients died. Compared with JIA, diagnosis of systemic lupus erythematosus, mixed connective tissue disease, vasculitis, or other RMD (OR 4.3; 95% CI 1.7 to 11) or autoinflammatory syndrome (OR 3.0; 95% CI 1.1 to 8.6) was associated with hospitalisation, as was obesity (OR 4.0; 95% CI 1.3 to 12). CONCLUSIONS: This is the most significant investigation to date of COVID-19 in CYP with RMDs. It is important to note that the majority of CYP were not hospitalised, although those with severe systemic RMDs and obesity were more likely to be hospitalised.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kearsley-Fleet L, Chang ML, Lawson-Tovey S, et al. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2022. PMID: 35338032. doi:10.1136/annrheumdis-2022-222241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。